Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

QC Ware and IonQ Achieve Chemical Accuracy in Hybrid Quantum Chemistry Workflow for ...

1 September 2026 · By · Wire by Fusion42

Published

1 September 2026

Topic

technology

◆ Sectors

Quantum ComputingCloud Infrastructure

◆ Source

Read at quantumcomputingreport.com →

◆ Verified

Fusion42 · 1 September 2026 · Fusion42 review

QC Ware and IonQ demonstrated a hybrid quantum-classical chemistry workflow that achieves chemical accuracy for modeling enzyme active sites, using QC Ware's Promethium platform and IonQ's Forte quantum computer via Amazon Braket and AWS cloud credits.

This Wire brief sits within Fusion42's coverage of Quantum Computing and Cloud Infrastructure.

◆ ◆ The Wire takeaway

Quantum computing just hit a reliability milestone for drug discovery modelling that changes your pipeline risk profile. If you develop tools for biopharma R&D, this opens new paths to early, practical quantum advantage on enzyme targets.

◆ Coverage

1 source · 1 Sep 2026

◆ Related on Wire

◆ Topics

Quantum ComputingCloud Infrastructurequantum-chemistrydrug-discoveryhybrid-quantum-classicalenzyme-modelingamazon-braket